What markers track hyaluronic acid?

Hyaluronic acid (HA), also written hyaluronan, is a non-sulfated glycosaminoglycan built from repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine. It is a high-molecular-weight polymer, and its molecular weight is itself one of the quantities most often tracked, because oxidative chain scission lowers it and that loss is read out as a change in formulation stability and functional performance [2]. In the research literature HA appears both as an analyte and as a component of delivery systems, hydrogels, dermal fillers and oral formulations, so the markers used to follow it depend on which of those roles is under study.

The mechanistic work centres on oxidative degradation of the HA chain and on the inflammatory signalling that surrounds it, with the NF-κB pathway and the NLRP3-TXNIP-iNOS axis recurring in the joint models and nanoparticle systems described below [3][5][8].

Research Studies

Ergothioneine and HA stability in a model wound-healing material

HA-based hydrogels are used as wound-healing materials and topical delivery systems because of their biocompatibility, water retention and ability to promote cell migration, but HA undergoes oxidative chain scission that reduces molecular weight and compromises formulation stability [2]. In a model HA-based wound-healing material, ergothioneine (EGT) was evaluated as a candidate antioxidant stabilising excipient. Biocompatibility was assessed by CCK-8 assay in L929 mouse fibroblasts after 24 h of exposure, alongside a stress-screening framework that included Fenton oxidation and high-temperature/high-humidity conditions [2].

Ectoine and NF-κB signalling in chondrocytes and a rat osteoarthritis model

Ectoine, a natural osmoprotectant, was tested for effects on NF-κB signalling in osteoarthritis. Primary rat chondrocytes were pretreated with ectoine at 0–3.0% w/v and then stimulated with IL-1β at 10 ng/mL; cell viability was evaluated and expression measured by RT-qPCR [3]. The study also examined whether ectoine mitigates osteoarthritis progression in a rat model [3].

Niacinamide-enriched cross-linked HA dermal filler and collagen stimulation

A niacinamide-enriched cross-linked HA dermal filler (HAR) was evaluated for biostimulatory, antimicrobial, anti-inflammatory and safety profiles against untreated controls and Belotero Balance® [4]. The rationale given is that biological skin ageing involves flattening of the epidermal–dermal junction and reduced collagen types I and III, and that niacinamide stimulates collagen synthesis, modulates inflammation and inhibits bacterial growth [4].

REJENERA and the NLRP3-TXNIP-iNOS axis in a rat knee osteoarthritis model

REJENERA©, a multi-component formula containing olive leaf bioflavonoids (ZeyEX©, quercetin and luteolin), S-allylcysteine, palmitoylethanolamide, L-proline, hyaluronic acid and boron, was studied in knee osteoarthritis and compared with ZeyEX, NPROC© and ibuprofen in a rat model [5]. Osteoarthritis was established by intra-articular injection of monosodium iodoacetate (MIA; 3 mg) into the right knee joint [5]. The reported mechanism centres on regulation of the NLRP3-TXNIP-iNOS axis and inflammation [5].

HA and folic acid-modified mesoporous silica nanoparticles delivering sulforaphane in NSCLC

Sulforaphane (SF) binds SPI1, inhibiting its activity and downregulating miR-616-5p, which attenuates NSCLC metastasis, but poor SF stability limits clinical application [8]. To address this, an HA and folic acid-modified mesoporous silica nanoparticle system delivering sulforaphane was developed, with SPI1/miR-616-5p as the axis under investigation [8].

Chlorhexidine mouthwash formulations and human gingival fibroblasts

An in vitro study is evaluating two chlorhexidine-based mouthwash formulations on the survival and function of human gingival fibroblasts (hGFs) [6]. Fibroblasts obtained from discarded gingival tissue collected during routine dental procedures are cultured and exposed to a conventional 0.2% chlorhexidine mouthwash or a 0.2% chlorhexidine mouthwash supplemented with N-acetylcysteine (NAC) and hyaluronic acid (HA) [6]. Cell viability, apoptosis, migration and gene expression are assessed at multiple time points using Trypan Blue exclusion, fluorescence-activated cell sorting, scratch assay and quantitative methods [6].

Oral HA drink and knee pain in a functional evaluation trial

A registered trial is evaluating the effect of an A+HA premium oral hyaluronic acid drink on relieving knee pain [1]. The endpoint is knee pain, which is a symptomatic measure rather than a molecular marker.

Oral EGCG, folic acid, vitamin B12 and HA in persistent HPV infection

An interventional, single-centre, open-label randomised clinical study is evaluating an oral dietary supplement (Pervistop®) combining epigallocatechin gallate (EGCG), folic acid, vitamin B12 and hyaluronic acid in women with persistent HPV infection [7]. The primary objective is to describe the effect of the combination on HPV DNA integration into the host genome by measuring clearance rate of the viral oncoproteins E6 and E7; 42 women aged 25 or older with persistent HPV infection and low-grade cervical lesions are randomised 1:1 [7].

Comparison of tracked markers across models

If you are reading this for personal health reasons

The materials described here are sold for laboratory research use only, and we do not provide dosing or medical guidance. Nothing on this page is a recommendation to take any compound. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

• [1] A+HA Premium Oral Hyaluronic Acid Drink Functional Evaluation Trial for Delaying Joint Pain — https://clinicaltrials.gov/study/NCT07800676
• [2] Effect of Ergothioneine on the Stability of Hyaluronic Acid-Based Wound-Healing Materials — https://europepmc.org/article/PMC/PMC13517268
• [3] Ectoine Inhibits IL-1β-Induced Inflammation by Suppressing the NF-κB Pathway in Chondrocytes and Alleviates Osteoarthritis in a Rat Model — https://europepmc.org/article/PMC/PMC13510090
• [4] A smarter dermal filler: Antimicrobial protection and collagen stimulation with niacinamide — https://pubmed.ncbi.nlm.nih.gov/42437592/
• [5] REJENERA©, a multi-component bioflavonoid-based formula, alleviates osteoarthritis and provides chondroprotection by regulating the NLRP3-TXNIP-iNOS axis and inflammation — https://europepmc.org/article/PMC/PMC13525066
• [6] Effects of Chlorhexidine on Human Gingival Fibroblasts — https://clinicaltrials.gov/study/NCT07669636
• [7] Effect of EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on HPV DNA Integration — https://clinicaltrials.gov/study/NCT07697196
• [8] Hyaluronic acid and folic acid-modified mesoporous silica nanoparticles delivering sulforaphane suppress NSCLC via SPI1/miR-616-5p axis — https://europepmc.org/article/PMC/PMC13276326
• [9] Temporally Optimized Antioxidant Serums for Daytime Defense and Nighttime Repair: A Multicenter Clinical Investigation — https://pubmed.ncbi.nlm.nih.gov/42728530/
• [10] Effects of Heidihuang Pill on renal fibrosis and senescence-associated changes in rats with unilateral ureteral obstruction — https://pubmed.ncbi.nlm.nih.gov/42700848/
• [11] Biologically Active Hyaluronic Acid-Conjugated Zn, Se-Doped Hydroxyapatite Nanobiocomposite — https://pubmed.ncbi.nlm.nih.gov/42690969/
• [12] Retraction notice to "Preparation of microfluidic-based pectin microparticles loaded carbon dots conjugated with BMP-2 embedded in gelatin-elastin-hyaluronic acid hydrogel scaffold for bone tissue engineering application" — https://pubmed.ncbi.nlm.nih.gov/42686482/